Kok‐Siong Chen

594 total citations
21 papers, 398 citations indexed

About

Kok‐Siong Chen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kok‐Siong Chen has authored 21 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Immunology. Recurrent topics in Kok‐Siong Chen's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and Virus-based gene therapy research (3 papers). Kok‐Siong Chen is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers) and Virus-based gene therapy research (3 papers). Kok‐Siong Chen collaborates with scholars based in United States, Australia and Malaysia. Kok‐Siong Chen's co-authors include Jens Bunt, Linda J. Richards, Jonathan W. C. Lim, Khalid Shah, Filippo Rossignoli, Hiroaki Wakimoto, Hany Ariffin, Reza Abdi, David A. Reardon and Richard M. Gronostajski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Nanotechnology.

In The Last Decade

Kok‐Siong Chen

20 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kok‐Siong Chen United States 12 211 109 85 66 63 21 398
Guishan Jin China 12 237 1.1× 140 1.3× 57 0.7× 120 1.8× 75 1.2× 31 464
Theresa Relation United States 8 213 1.0× 146 1.3× 76 0.9× 82 1.2× 70 1.1× 16 412
Christine Günther Germany 9 189 0.9× 147 1.3× 91 1.1× 42 0.6× 136 2.2× 20 451
Simon Khagi United States 9 101 0.5× 113 1.0× 67 0.8× 45 0.7× 110 1.7× 28 325
Ryan Lahey United States 5 136 0.6× 134 1.2× 62 0.7× 67 1.0× 77 1.2× 7 355
Kathleen S. Ensbey Australia 12 251 1.2× 138 1.3× 76 0.9× 72 1.1× 86 1.4× 22 430
Vanesa Alonso-Camino Spain 10 135 0.6× 158 1.4× 51 0.6× 31 0.5× 62 1.0× 16 296
Yeon Sook Choi United States 10 351 1.7× 154 1.4× 52 0.6× 111 1.7× 34 0.5× 12 658
Thomas Moreau United Kingdom 10 240 1.1× 117 1.1× 54 0.6× 41 0.6× 30 0.5× 19 441
Luca Orlando Italy 14 354 1.7× 94 0.9× 55 0.6× 64 1.0× 28 0.4× 30 484

Countries citing papers authored by Kok‐Siong Chen

Since Specialization
Citations

This map shows the geographic impact of Kok‐Siong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kok‐Siong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kok‐Siong Chen more than expected).

Fields of papers citing papers by Kok‐Siong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kok‐Siong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kok‐Siong Chen. The network helps show where Kok‐Siong Chen may publish in the future.

Co-authorship network of co-authors of Kok‐Siong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kok‐Siong Chen. A scholar is included among the top collaborators of Kok‐Siong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kok‐Siong Chen. Kok‐Siong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LIU, Chuang, Xiangang Huang, Kok‐Siong Chen, et al.. (2025). Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles. Nature Nanotechnology. 20(10). 1526–1538. 7 indexed citations
2.
Chen, Kok‐Siong, Nobuhiko Kanaya, Mian Wang, et al.. (2025). Antitumor Immunity Mediated by Engineered Stem Cells Exploiting TRAIL-Induced Cell Death and FLT3L Immunomodulation. Clinical Cancer Research. 31(13). 2793–2813. 1 indexed citations
3.
Kanaya, Nobuhiko, et al.. (2025). Engineered allogeneic stem cells orchestrate T lymphocyte–driven immunotherapy in immunosuppressive leptomeningeal brain metastasis. JNCI Journal of the National Cancer Institute. 117(6). 1151–1165. 3 indexed citations
4.
Chen, Kok‐Siong & Khalid Shah. (2025). Beyond safety: suicide systems in cell-based cancer therapies. Trends in cancer. 11(10). 966–978.
5.
Chen, Kok‐Siong, Nobuhiko Kanaya, Yi-Ching Chen, et al.. (2024). An inducible RIPK3-driven necroptotic system enhances cancer cell–based immunotherapy and ensures safety. Journal of Clinical Investigation. 135(2). 5 indexed citations
6.
Chen, Kok‐Siong, et al.. (2024). Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice. Frontiers in Immunology. 14. 1324618–1324618. 9 indexed citations
7.
Kanaya, Nobuhiko, Yohei Kitamura, Kok‐Siong Chen, et al.. (2023). Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Science Translational Medicine. 15(698). eade8732–eade8732. 13 indexed citations
8.
Chen, Kok‐Siong, Clemens Reinshagen, Filippo Rossignoli, et al.. (2023). Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity. Science Translational Medicine. 15(677). eabo4778–eabo4778. 54 indexed citations
9.
Wang, Mian, Kok‐Siong Chen, Wanlu Li, et al.. (2023). Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors. Biomedicine & Pharmacotherapy. 162. 114665–114665. 12 indexed citations
10.
Morcom, Laura, Timothy J. Edwards, Dorothy M. Jones, et al.. (2021). DRAXIN regulates interhemispheric fissure remodelling to influence the extent of corpus callosum formation. eLife. 10. 10 indexed citations
11.
Chen, Kok‐Siong, et al.. (2021). Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?. Frontiers in Oncology. 11. 678562–678562. 27 indexed citations
12.
Song, Na, Hiroaki Wakimoto, Filippo Rossignoli, et al.. (2021). Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm. Stem Cells. 39(6). 707–722. 41 indexed citations
13.
Tawfik, Essam A., et al.. (2021). Immunotherapy in Hematological Malignancies: Recent Advances and Open Questions. Immunotherapy. 13(14). 1215–1229. 11 indexed citations
14.
Chen, Kok‐Siong, Jonathan W. C. Lim, Thomas Robertson, et al.. (2020). NFIA and NFIB function as tumour suppressors in high-grade glioma in mice. Carcinogenesis. 42(3). 357–368. 11 indexed citations
15.
Houston, Zachary H., Jens Bunt, Kok‐Siong Chen, et al.. (2020). Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies. ACS Central Science. 6(5). 727–738. 43 indexed citations
16.
Chen, Kok‐Siong, Jonathan W. C. Lim, Brett W. Stringer, et al.. (2019). Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma. Journal of Neuro-Oncology. 146(1). 41–53. 16 indexed citations
17.
Chen, Kok‐Siong, Jonathan W. C. Lim, Linda J. Richards, & Jens Bunt. (2017). The convergent roles of the nuclear factor I transcription factors in development and cancer. Cancer Letters. 410. 124–138. 69 indexed citations
18.
Chen, Kok‐Siong, Lachlan Harris, Jonathan W. C. Lim, et al.. (2017). Differential neuronal and glial expression of nuclear factor I proteins in the cerebral cortex of adult mice. The Journal of Comparative Neurology. 525(11). 2465–2483. 29 indexed citations
19.
Ariffin, Hany, Pierre Hainaut, Anna M. Puzio‐Kuter, et al.. (2014). Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li–Fraumeni cancer predisposition syndrome. Proceedings of the National Academy of Sciences. 111(43). 15497–15501. 19 indexed citations
20.
Chen, Kok‐Siong, et al.. (2012). Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations. Clinical Genetics. 82(6). 564–568. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guishan Jin Breakdown of academic impact, for papers by Theresa Relation Breakdown of academic impact, for papers by Christine Günther Breakdown of academic impact, for papers by Simon Khagi Breakdown of academic impact, for papers by Ryan Lahey Breakdown of academic impact, for papers by Kathleen S. Ensbey Breakdown of academic impact, for papers by Vanesa Alonso-Camino Breakdown of academic impact, for papers by Yeon Sook Choi Breakdown of academic impact, for papers by Thomas Moreau Breakdown of academic impact, for papers by Luca Orlando
Rankless by CCL
2026